Literature DB >> 6861870

Procaine hydrolysis defect in uraemia does not appear to be due to carbamylation of plasma esterases.

R Calvo, R Carlos, S Erill.   

Abstract

Procaine esterase activity in plasma from patients with renal failure is decreased by 40%. Since cyanate is formed from urea and readily carbamylates certain blood proteins, a possible role for cyanate in the depression of plasma esterase activity in uraemic patients was considered. However, in vitro carbamylation of normal plasma in a range similar to that detected in uraemic patients did not influence procaine esterase activity. Kinetic analysis of the reaction showed that the maximal hydrolyzing capacity but not the Km in uraemic plasma was diminished (5.0 +/- 0.3 X 10(-5) moles hydrolyzed per litre of plasma per minute and a Km of 3.9 +/- 0.2 X 10(-5) mol/l in plasma from normal volunteers as compared to 3.1 +/- 0.1 X 10(-5) mol/l/min and 3.5 +/- 0.2 X 10(-5) ml/l in plasma from patients with renal failure). Therefore, not carbamylation but rather a decrease in enzyme synthesis is the likely explanation for the lower rate of procaine hydrolysis in uraemic plasma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861870     DOI: 10.1007/bf00609899

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Specificity of esterases. I. Identification of two pancreatic aliesterases.

Authors:  B H J HOFSTEE
Journal:  J Biol Chem       Date:  1952-11       Impact factor: 5.157

2.  Elevated plasma procaine concentrations after administration of procaine penicillin G.

Authors:  R L Green; J E Lewis; S J Kraus; E L Frederickson
Journal:  N Engl J Med       Date:  1974-08-01       Impact factor: 91.245

3.  The rate of procaine hydrolysis in serum of normal subjects and diseased patients.

Authors:  M M Reidenberg; M James; L G Dring
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

4.  Metabolism of procainamide and p-aminobenzoic acid in patients with chronic liver disease.

Authors:  P du Souich; S Erill
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

5.  A possible role for cyanate in the albumin binding defect of uremia.

Authors:  K Bachmann; M Valentovic; R Shapiro
Journal:  Biochem Pharmacol       Date:  1980-06-01       Impact factor: 5.858

6.  Hemoglobin carbamylation in uremia.

Authors:  R Flückiger; W Harmon; W Meier; S Loo; K H Gabbay
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

7.  Local anesthetic-induced convulsions in man--an electroencephalographic study.

Authors:  J E Usubiaga; J Wikinski; R Ferrero; L E Usubiaga; R Wikinski
Journal:  Anesth Analg       Date:  1966 Sep-Oct       Impact factor: 5.108

8.  A sensitive and convenient micromethod for estimation of urea, citrulline, and carbamyl derivatives.

Authors:  D Hunninghake; S Grisolia
Journal:  Anal Biochem       Date:  1966-08       Impact factor: 3.365

9.  Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure.

Authors:  P du Souich; S Erill
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

10.  Plasma protein carbamylation and decreased acidic drug protein binding in uremia.

Authors:  S Erill; R Calvo; R Carlos
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.